Inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS), as conditions that affect the gastrointestinal tract and cause significant discomfort or pain in the abdomen, can often get ...

Irritable bowel syndrome, or IBS, is a chronic disorder of the gastrointestinal system that affects the quality of life in children and adults. Symptoms include varying types of abdominal discomfort ...

Irritable bowel syndrome (IBS) is a digestive disorder that causes abdominal pain, bloating, gas, diarrhea, and constipation--or some combination of these problems. IBS affects people of all ages, ...

Initially approved in 2012, linaclotide is already indicated for treating chronic idiopathic constipation and IBS-C in adults. The FDA in 2023 also approved linaclotide capsules for treating ...

The FDA has approved linaclotide (Linzess) for children aged 7 years or older with irritable bowel syndrome with constipation (IBS-C), making it the first approved treatment for pediatric IBS-C. The ...

Please provide your email address to receive an email when new articles are posted on . The FDA expanded linaclotide approval for IBS-C to include children aged 7 years and older. Linaclotide is now ...

The new approval that came from the USFDA makes it sure that the Linzess is safe and effective, bringing a sense of relief for parents and children with the digestive disorder condition called IBS-C.

What Is It, and Why Does It Matter? Linzess (linaclotide) is a prescription medicine that helps ease constipation caused by irritable bowel syndrome (IBS-C). It works by drawing more fluid into your ...

The FDA has approved Linzess (linaclotide) for children aged 7 and older with IBS-C, marking the first FDA-approved drug for this condition in younger patients. This medication helps improve bowel ...

The FDA has approved Linzess capsules for treating irritable bowel syndrome with constipation in pediatric patients seven years and older, according to a Nov. 5 news release. Here are five things to ...